A medication being more expensive usually indicates rarity. This means the instance of required coverage by insurance companies is also rare. The fact any medication, needed to mitigate the risk of simply being born, might not be covered by “insurance” is bonkers.
I think we need to start a new industry to take it to insurance companies every time they deny coverage. Bury them in complaints and legal actions. Go so hard on every case that they give in immediately upon seeing the letterhead.
I knew a guy with AIDS that had some pills to take like once a month I think that were around that price and also struggled with coverage. I didn’t think AIDS was considered rare.
I don’t know what time period you knew this guy, but back in the 90s when the first retrovirals came out it was not a friendly place for gay people, especially gay men.
I actively covered for at least two in workplace situations where bosses were hinting/asking around about questionable sexual orientation, and made up brief scenarios where I’d seen them out with some beautiful woman just to throw these assholes off the track, if only because I knew how it would be for them at work if anyone found out: the prelude hell of whispers and glances, then open harassment, then complete loss of employment.
One of them, who ended up being a good friend, was also HIV+ and stared this exact scenario in the face on multiple occasions, but got his retrovirals through one of the first studies so at least that specific healthcare access wasn’t threatened.
And remember the statement at the top of this thread:
The fact that your employment in the US determines what medical care you can get is absolutely bonkers.
AIDS was not rare at all. It is still not rare in many parts of the world. But you could not get a better group of people to marginalize, deny, and treat criminally than gay men in the 80s and 90s – especially ones who had to keep their sexuality completely hidden from employers just to have jobs and health insurance in the first place.
My medicine is $1,500 a month without insurance. It’s a bipolar medication. It doesn’t indicate rarity, it indicates greed. They could easily sell it for half the price and still make money.
It’s important to keep in mind that this rarity is often artificial scarcity by the pharmaceutical companies. There are some conditions which are rare, but have treatments that have been available for decades now with generics on the market for years. They simply don’t produce much of those meds, even though it’s cheap to do so, in order to artificially inflate the market price.
Insurers are complicit in this scheme because they don’t push back on this practice at all. Without single payer, we have no negotiating force to get pharmaceuticals to produce drugs in an affordable way, so they can manipulate the market however they please. It’s absolutely depraved.
That’s their point. If I need to setup a production facility but there’s only demand for a thousand doses a year, then the long term capital costs are going to drive the unit price up.
But there’s also greed. Stuff that’s a dollar to make and a thousand dollars to use.
A medication being more expensive usually indicates rarity. This means the instance of required coverage by insurance companies is also rare. The fact any medication, needed to mitigate the risk of simply being born, might not be covered by “insurance” is bonkers.
I think we need to start a new industry to take it to insurance companies every time they deny coverage. Bury them in complaints and legal actions. Go so hard on every case that they give in immediately upon seeing the letterhead.
I think insurance companies are useless parasites that should all have been outmoded by single payer decades ago.
I knew a guy with AIDS that had some pills to take like once a month I think that were around that price and also struggled with coverage. I didn’t think AIDS was considered rare.
I don’t know what time period you knew this guy, but back in the 90s when the first retrovirals came out it was not a friendly place for gay people, especially gay men.
I actively covered for at least two in workplace situations where bosses were hinting/asking around about questionable sexual orientation, and made up brief scenarios where I’d seen them out with some beautiful woman just to throw these assholes off the track, if only because I knew how it would be for them at work if anyone found out: the prelude hell of whispers and glances, then open harassment, then complete loss of employment.
One of them, who ended up being a good friend, was also HIV+ and stared this exact scenario in the face on multiple occasions, but got his retrovirals through one of the first studies so at least that specific healthcare access wasn’t threatened.
And remember the statement at the top of this thread:
AIDS was not rare at all. It is still not rare in many parts of the world. But you could not get a better group of people to marginalize, deny, and treat criminally than gay men in the 80s and 90s – especially ones who had to keep their sexuality completely hidden from employers just to have jobs and health insurance in the first place.
My medicine is $1,500 a month without insurance. It’s a bipolar medication. It doesn’t indicate rarity, it indicates greed. They could easily sell it for half the price and still make money.
It’s important to keep in mind that this rarity is often artificial scarcity by the pharmaceutical companies. There are some conditions which are rare, but have treatments that have been available for decades now with generics on the market for years. They simply don’t produce much of those meds, even though it’s cheap to do so, in order to artificially inflate the market price.
Insurers are complicit in this scheme because they don’t push back on this practice at all. Without single payer, we have no negotiating force to get pharmaceuticals to produce drugs in an affordable way, so they can manipulate the market however they please. It’s absolutely depraved.
Most meds take dollars to make. It ain’t rarity.
That’s their point. If I need to setup a production facility but there’s only demand for a thousand doses a year, then the long term capital costs are going to drive the unit price up.
But there’s also greed. Stuff that’s a dollar to make and a thousand dollars to use.